Neurobiology and genetics of behavioural syndromes of Alzheimer's disease
- PMID: 15975078
- DOI: 10.2174/1567205043332180
Neurobiology and genetics of behavioural syndromes of Alzheimer's disease
Abstract
The number of people with cognitive impairment is rising in parallel with changing demographics. As health care budgets are coming under increasing strain with regard to the provision of nursing care, there is a substantial need for effective therapies which encompass greater understanding of the components of dementia that finally necessitate admission to residential or nursing home care. Behavioural and psychological symptoms of dementia (BPSD) are major independent risk factors for admission to institutional care and research into the origin of BPSD is gathering pace. In this review, we evaluate the neurobiological and genetic changes described in individuals with BPSD in Alzheimer's disease. Particular emphasis is placed on genetic theories of causation, namely that BPSD results directly or indirectly from known genetic risk factors for AD, or distinct genetic risk factors for psychiatric illness assume clinical significance within the degenerated Alzheimer's brain.
Similar articles
-
Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?Cortex. 2015 Dec;73:36-61. doi: 10.1016/j.cortex.2015.07.032. Epub 2015 Aug 13. Cortex. 2015. PMID: 26343344 Review.
-
Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.J Alzheimers Dis. 2009;17(2):441-8. doi: 10.3233/JAD-2009-1054. J Alzheimers Dis. 2009. PMID: 19363270
-
Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.J Alzheimers Dis. 2014;39(3):669-77. doi: 10.3233/JAD-131337. J Alzheimers Dis. 2014. PMID: 24254701
-
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.J Alzheimers Dis. 2014;39(3):477-85. doi: 10.3233/JAD-131190. J Alzheimers Dis. 2014. PMID: 24164733 Clinical Trial.
-
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.Mech Ageing Dev. 2006 Feb;127(2):158-65. doi: 10.1016/j.mad.2005.09.016. Epub 2005 Nov 16. Mech Ageing Dev. 2006. PMID: 16297434 Review.
Cited by
-
Neuroprotective Effects of Centella asiatica against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress.Int J Alzheimers Dis. 2009 Sep 13;2009:972178. doi: 10.4061/2009/972178. Int J Alzheimers Dis. 2009. PMID: 20798885 Free PMC article.
-
Physical exercise is effective for neuropsychiatric symptoms in Alzheimer's disease: a systematic review.Arq Neuropsiquiatr. 2021 May;79(5):447-456. doi: 10.1590/0004-282X-ANP-2020-0284. Arq Neuropsiquiatr. 2021. PMID: 34161531 Free PMC article.
-
Neurobiology of neuropsychiatric symptoms in Alzheimer's disease: A critical review with a focus on neuroimaging.Dement Neuropsychol. 2013 Jul-Sep;7(3):236-243. doi: 10.1590/S1980-57642013DN70300002. Dement Neuropsychol. 2013. PMID: 29213845 Free PMC article. Review.
-
Hesperidin ameliorates immobilization-stress-induced behavioral and biochemical alterations and mitochondrial dysfunction in mice by modulating nitrergic pathway.ISRN Pharmacol. 2012;2012:479570. doi: 10.5402/2012/479570. Epub 2012 Mar 29. ISRN Pharmacol. 2012. PMID: 22550596 Free PMC article.
-
Pimavanserin for the treatment of psychosis in Alzheimer's disease: A literature review.World J Psychiatry. 2020 Jul 19;10(7):162-174. doi: 10.5498/wjp.v10.i7.162. eCollection 2020 Jul 19. World J Psychiatry. 2020. PMID: 32844093 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials